News

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Scholars of communication from Africa and Europe have called for the deployment of strategic communication as a tool for social change and improved standard of living. At a virtual meeting to ...
Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon ...
From left: Haleon Lanka Snr. Manager – Medical Marketing Satheeskanth Sithambaram, Marketing Lead Harsha Ratnayake, Commercial Lead – Sri Lanka and Maldives Manjula Weerakoon, Managing Director – Sri ...
Head of Expert at Haleon South Africa, Macelle Erasmus, a leader in consumer health and self-care, said: “Oral health is not just about bright smiles and good-looking teeth. It is a critical ...
Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare group. As part of the transaction, Haleon, known for household brands like ...
Sensodyne toothpaste maker Haleon hailed an ‘important milestone’ as an independent company after US pharma giant Pfizer sold its remaining stake in the business. Shares in the consumer health ...
Under the deal, Sensodyne maker Haleon has agreed to buy back 44 million shares from Pfizer, currently its largest shareholder, with 618 million shares being sold to institutional investors. The total ...
Pfiz­er will get about $3.3 bil­lion from its fi­nal stake sale in Ha­le­on, ac­cord­ing to a Wednes­day fil­ing with the Lon­don … ...
Pfizer (NYSE:PFE) has generated £2.5B ($3.24B) after selling its entire stake in Haleon (NYSE:HLN), the consumer healthcare company it established with the British pharmaceutical giant GSK (GSK ...
Pfizer sold its remaining 7.3% stake in Haleon for $3.1 billion, fully exiting its position in the company. Haleon expects 2025 organic revenue growth of 4% to 6%, with stronger performance in the ...